GS0421: Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research in the field of cancer treatment; providing information on clinical studies via an interactive website
Case File Event Statements
11/3/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
10/15/2021 - 3 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
7/15/2022 - 2 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
7/28/2022 - 2 years ago
4 - NON-FINAL ACTION WRITTENType:CNRT
7/28/2022 - 2 years ago
5 - NON-FINAL ACTION E-MAILEDType:GNRT
7/28/2022 - 2 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
12/9/2022 - 2 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
12/9/2022 - 2 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
12/9/2022 - 2 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
12/12/2022 - 2 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
1/17/2023 - a year ago
12 - PUBLISHED FOR OPPOSITIONType:PUBO
1/17/2023 - a year ago
13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
12/28/2022 - 2 years ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
3/14/2023 - a year ago
14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
9/8/2023 - a year ago
15 - SOU TEAS EXTENSION RECEIVEDType:EEXT
9/12/2023 - a year ago
18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
9/8/2023 - a year ago
16 - SOU EXTENSION 1 FILEDType:EXT1
9/8/2023 - a year ago
17 - SOU EXTENSION 1 GRANTEDType:EX1G
10/4/2023 - a year ago
19 - ASSIGNED TO EXAMINERType:DOCK
3/7/2024 - 10 months ago
20 - SOU TEAS EXTENSION RECEIVEDType:EEXT
3/7/2024 - 10 months ago
21 - SOU EXTENSION 2 FILEDType:EXT2
3/7/2024 - 10 months ago
22 - SOU EXTENSION 2 GRANTEDType:EX2G
10/21/2024 - 2 months ago
24 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
10/21/2024 - 2 months ago
25 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDType:MAB6
3/8/2024 - 10 months ago
23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA